MTOR and cancer: Mechanistically, for the first time, we revealed that FGFR inhibition suppressed HK2 gene transcription via inhibiting mTOR in FGFRi-sensitive in vitro and in vivo cancer models with different FGFR1-4 anomalies (Figure 6).